The MitraClip has been a strong growth driver for Abbott this year.
News & Features
Device and drug makers can use this recommended approach to help streamline clinical trials and increase the odds of regulatory success.
Everything you need to know about transcatheter mitral valve therapies, the latest in drug-eluting stents, and other key findings presented at this year's Transcatheter Cardiovascular Therapeutics meeting.
First study findings of Intuitive Surgical's flexible robotics platform suggest it provides a safe and practical approach for sampling lung tissue.
Implantable medical devices containing highly sophisticated electronics are lasting longer than before, raising the bar for safety and liability.
MD&M Minneapolis is the place to see the latest and greatest offerings from medtech industry suppliers and service providers, and you'll definitely want to check out these five products at the show.
Stryker posted solid third-quarter results despite hurricanes, a product recall, and other headwinds.
BD still plans to enter the estimated $1 billion market for insulin patch pumps for patients with type 2 diabetes, but its first product won't launch as soon as the company initially anticipated.
FDA and Philips reached an agreement regarding manufacturing issues involving the company's automatic external defibrillators.
Faced with an ongoing CEO search and manufacturing problems, Zimmer Biomet's third-quarter financials missed the mark on both revenue and earnings per share. But there may be a turnaround in sight.
There is a fine line that, when crossed, turns a sales rep from an asset to both manufacturers and surgeons into a potential liability for third-party claims.
A digital labeling expert points out that adopting digital processes might have benefits for multiple areas of medical device manufacturing.
After a six-year hiatus from the coronary stent business, Cordis just inked an exclusive distribution deal for two heart stents.